Literature DB >> 14763994

Serum testosterone levels in males with Alzheimer's disease.

C Pennanen1, M P Laakso, M Kivipelto, J Ramberg, H Soininen.   

Abstract

This study aimed to investigate whether there are differences in serum testosterone levels between male patients with Alzheimer's disease (AD) and cognitively normal male controls. Testosterone and sex hormone binding globulin (SHBG) levels were measured from 14 patients with mild to moderate AD and 16 age-matched control males. The AD patients had higher levels of serum total (P = 0.02) and free testosterone (P < 0.001), and higher free androgen index (FAI) (P = 0.02) compared to controls. No differences were found for the SHBG levels. These data provide no support for hypotheses of (disproportionally) decreased levels of serum testosterone in AD. These data also show that all cognitively normal controls had an FAI below the normal range.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14763994     DOI： 10.1111/j.0953-8194.2004.01133.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN： 0953-8194            Impact factor:   3.627


  9 in total

Review 1.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 2.  Sex and the development of Alzheimer's disease.

Authors:  Christian J Pike
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 3.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

4.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

Review 5.  Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

Authors:  Emily R Rosario; Christian J Pike
Journal:  Brain Res Rev       Date:  2007-07-07

Review 6.  Androgen cell signaling pathways involved in neuroprotective actions.

Authors:  Christian J Pike; Thuy-Vi V Nguyen; Martin Ramsden; Mingzhong Yao; M Paul Murphy; Emily R Rosario
Journal:  Horm Behav       Date:  2007-11-22       Impact factor: 3.587

Review 7.  The Prevalence of Alzheimer's Disease in China: A Systematic Review and Meta-analysis.

Authors:  Kanglan Li; Shouchao Wei; Zhou Liu; Li Hu; Jiajing Lin; Shiting Tan; Yingren Mai; Wanjuan Peng; Hui Mai; Qi Hou; Guifeng Tu
Journal:  Iran J Public Health       Date:  2018-11       Impact factor: 1.429

8.  Factors Influencing Change in Brain-Predicted Age Difference in a Cohort of Healthy Older Individuals.

Authors:  Jo Wrigglesworth; Ian H Harding; Phillip Ward; Robyn L Woods; Elsdon Storey; Bernadette Fitzgibbon; Gary Egan; Anne Murray; Raj C Shah; Ruth E Trevaks; Stephanie Ward; John J McNeil; Joanne Ryan
Journal:  J Alzheimers Dis Rep       Date:  2022-04-04

9.  Testosterone profile in older men with Alzheimer's disease.

Authors:  Cristiana Roscito Arenella Dusi; Lílian Schafirovits Morillo; Regina Miksian Magaldi; Adriana Nunes Machado; Sami Liberman; Wilson Jacob Filho
Journal:  Dement Neuropsychol       Date:  2008 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.